Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-02-25. With its vertically integrated approach, the Company owns and operates two purpose built 10,000-square-foot licensed production sites in Princeton, British Columbia and holds a Drug Establishment Licence (DEL), as issued by Health Canada. Additionally, it holds a Dealer’s Licence under Canada’s Narcotic Control Regulations, allowing the Company to possess, produce, assemble, sell and deliver psilocybin and other psychedelic substances within the regulated framework set forth by Health Canada.
OPTHF stock price ended at $0.25 on 金曜日, after rising 4.17%
On the latest trading day Feb 06, 2026, the stock price of OPTHF rose by 4.17%, climbing from $0.23 to $0.25. During the session, the stock saw a volatility of 8.70%, with prices oscillating between a daily low of $0.23 and a high of $0.25. Notably, trading volume dropped by 48.2K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 89.9K shares were traded, equating to a market value of approximately $24.1M.